Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Questcor Pharmaceuticals acquires Canadian API firm BioVectra
7:27 AM MST | January 8, 2013 | Deepti Ramesh
Pharmaceutical ingredients manufacturer BioVectra (Charlottetown, PE) says that biopharmaceutical company Questcor Pharmaceuticals (Anaheim Hills, CA) has signed a definitive agreement to acquire all issued and outstanding shares of BioVectra for an upfront payment of C$50 million ($50.7 million). BioVectra is a supplier of contract manufacturing services to the global pharmaceutical and biotechnology industry, and manufactures active pharmaceutical ingredients (API), chemical intermediates, and bioprocessing reagents. BioVectra had sales of about $28 million in...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee